Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Videos

Stentectomy by an Entrapped Rotational Atherectomy Burr

Ahmed Al-Ogaili, MD
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI
08/05/2024

Video 1. Coronary angiography demonstrated multiple severe and heavily calcified stenoses in the mid- and distal left anterior descending artery in previously implanted stents.

Video 2. Upon withdrawal, the burr became entrapped in the mid-left anterior descending artery within a stented segment.

Video 3. Advancement of a guide catheter extension over the burr into the mid-left anterior descending artery.  

Video 4. After multiple attempts and pulling the guidewire, the entrapped burr was removed.

Video 5. Angioplasty was performed with intravascular lithotripsy and non-compliant balloons.

Video Supplement to "Stentectomy by an Entrapped Rotational Atherectomy Burr" (Clinical Image).

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 
 


Advertisement

Advertisement

Advertisement

News

NPO
SCOFF Trial Confirms Fasting Not Needed Before Cath Lab Procedures
09/09/2024
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased...
09/09/2024
Cath Lab Digest
Non-Cardiac Surgery
ASSURE DES Trial: No Difference in Ischemic Events if Aspirin Interrupted or Continued in Patients With Coronary Stents Undergoing Non-Cardiac Surgery
09/09/2024
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no...
09/09/2024
Cath Lab Digest
TAVI
NOTION-3 Trial Investigates How to Manage CAD in Patients Undergoing Valve Implantation
09/09/2024
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial,...
09/09/2024
Cath Lab Digest
T-TEER
Tri.fr Trial: New Evidence for Benefits of Transcatheter Edge-to-Edge Repair in Secondary Tricuspid Regurgitation
09/09/2024
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid...
09/09/2024
Cath Lab Digest
MEETINGS
ACC Quality Summit Highlights Critical Value of ACC Accreditation and NCDR Services
09/06/2024
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of...
09/06/2024
Cath Lab Digest
TAVR
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
09/06/2024
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the...
09/06/2024
Cath Lab Digest
Risk Factors
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S. 
09/05/2024
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart...
09/05/2024
Cath Lab Digest
Pharmaceutical Therapy
Long-Term Follow-Up Data From Phase 3 Study of Camzyos (mavacamten) Underscores Established Efficacy and Safety Profile in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
09/04/2024
With inclusion in both the ESC and AHA/ACC clinical guidelines as a recommended option for when symptoms persist after first-line therapy, CAMZYOS is a standard of care for symptomatic oHCM.
With inclusion in both the ESC and AHA/ACC clinical guidelines as a recommended option for when symptoms persist after first-line therapy, CAMZYOS is a standard of care for symptomatic oHCM.
With inclusion in both the ESC...
09/04/2024
Cath Lab Digest
Pharmaceutical Therapy
Late-Breaking Kerendia (finerenone) Investigational Data Show Reduction in Cardiovascular Death and Total Heart Failure Events in Adults with Heart Failure With Mildly Reduced or Preserved Ejection Fraction
09/04/2024
Kerendia is the first-and-only non-steroidal mineralocorticoid receptor antagonist (MRA) to meet a primary composite cardiovascular endpoint in a Phase III trial investigating patients with HF and LVEF ≥40%.(1)
Kerendia is the first-and-only non-steroidal mineralocorticoid receptor antagonist (MRA) to meet a primary composite cardiovascular endpoint in a Phase III trial investigating patients with HF and LVEF ≥40%.(1)
Kerendia is the first-and-only...
09/04/2024
Cath Lab Digest
AI
Viz.ai and Cleerly Partner on Heart Disease Evaluation Using Artificial Intelligence
09/04/2024
Cleerly has pioneered the development of several leading FDA-approved softwares that use coronary computed tomography angiography (CCTA) images with advanced AI algorithms to detect ischemia and stenosis, and identify, quantify, and...
Cleerly has pioneered the development of several leading FDA-approved softwares that use coronary computed tomography angiography (CCTA) images with advanced AI algorithms to detect ischemia and stenosis, and identify, quantify, and...
Cleerly has pioneered the...
09/04/2024
Cath Lab Digest

Advertisement

Advertisement

NPO
SCOFF Trial Confirms Fasting Not Needed Before Cath Lab Procedures
09/09/2024
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased...
09/09/2024
Cath Lab Digest
Non-Cardiac Surgery
ASSURE DES Trial: No Difference in Ischemic Events if Aspirin Interrupted or Continued in Patients With Coronary Stents Undergoing Non-Cardiac Surgery
09/09/2024
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no...
09/09/2024
Cath Lab Digest
TAVI
NOTION-3 Trial Investigates How to Manage CAD in Patients Undergoing Valve Implantation
09/09/2024
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial,...
09/09/2024
Cath Lab Digest
T-TEER
Tri.fr Trial: New Evidence for Benefits of Transcatheter Edge-to-Edge Repair in Secondary Tricuspid Regurgitation
09/09/2024
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid...
09/09/2024
Cath Lab Digest
MEETINGS
ACC Quality Summit Highlights Critical Value of ACC Accreditation and NCDR Services
09/06/2024
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of Cardiology (ACC) Quality Summit 2024 will take place on September 17-19 in San Antonio, bringing together cardiovascular leaders from across the nation to discuss the value of NCDR services and quality programs.
The American College of...
09/06/2024
Cath Lab Digest
TAVR
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
09/06/2024
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the Venus-Endura technology, which integrates multiple anti-calcification techniques, immunogenicity removal technology and 3D force-controlled dehydration technology, providing exceptional durability, biocompatibility,...
Venus-Vitae utilizes the...
09/06/2024
Cath Lab Digest
Risk Factors
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S. 
09/05/2024
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart health of 746 Chinese Americans in both Los Angeles and Chicago over a period of roughly 18 years. Participants who resided in Chicago showed lower mortality levels from heart disease compared to those who lived...
The study observed the heart...
09/05/2024
Cath Lab Digest
Pharmaceutical Therapy
Long-Term Follow-Up Data From Phase 3 Study of Camzyos (mavacamten) Underscores Established Efficacy and Safety Profile in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
09/04/2024
With inclusion in both the ESC and AHA/ACC clinical guidelines as a recommended option for when symptoms persist after first-line therapy, CAMZYOS is a standard of care for symptomatic oHCM.
With inclusion in both the ESC and AHA/ACC clinical guidelines as a recommended option for when symptoms persist after first-line therapy, CAMZYOS is a standard of care for symptomatic oHCM.
With inclusion in both the ESC...
09/04/2024
Cath Lab Digest
Pharmaceutical Therapy
Late-Breaking Kerendia (finerenone) Investigational Data Show Reduction in Cardiovascular Death and Total Heart Failure Events in Adults with Heart Failure With Mildly Reduced or Preserved Ejection Fraction
09/04/2024
Kerendia is the first-and-only non-steroidal mineralocorticoid receptor antagonist (MRA) to meet a primary composite cardiovascular endpoint in a Phase III trial investigating patients with HF and LVEF ≥40%.(1)
Kerendia is the first-and-only non-steroidal mineralocorticoid receptor antagonist (MRA) to meet a primary composite cardiovascular endpoint in a Phase III trial investigating patients with HF and LVEF ≥40%.(1)
Kerendia is the first-and-only...
09/04/2024
Cath Lab Digest
AI
Viz.ai and Cleerly Partner on Heart Disease Evaluation Using Artificial Intelligence
09/04/2024
Cleerly has pioneered the development of several leading FDA-approved softwares that use coronary computed tomography angiography (CCTA) images with advanced AI algorithms to detect ischemia and stenosis, and identify, quantify, and...
Cleerly has pioneered the development of several leading FDA-approved softwares that use coronary computed tomography angiography (CCTA) images with advanced AI algorithms to detect ischemia and stenosis, and identify, quantify, and...
Cleerly has pioneered the...
09/04/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement